The founder of the VitaDAO, a decentralized autonomous organization (DAO) aimed at funding longevity research projects, has launched a new protocol called BIO. The goal of this protocol is to enable global patients, scientists, and biotech developers to collectively provide funding support for the development and commercialization of new therapies. The protocol raises funds through DAO and utilizes the proceeds from token sales to support relevant biotech projects, thus achieving the sharing of intellectual property. BIO raised $6.2 million in its initial Token Generation Event (TGE) through public sales, with participants including Zee Prime and 1kx, among other venture capital firms. Details of the second TGE will be announced soon.